Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

NCT00770445 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Pioglitazone and insulin
DRUG: Pioglitazone and metformin and insulin
DRUG: Metformin and insulin

Sponsor

Takeda